Jonathan E. Lim, President, CEO at HALOZYME THERAPEUTICS INC (HALO), sold 25,000 shares at $8.75 ($220K) on 2007-09-28, disclosed to the SEC on 2007-10-02.
Scheduled sale ($220k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.59 | 200 | $2K | 0.8% |
| 2 | $8.63 | 300 | $3K | 1.2% |
| 3 | $8.65 | 100 | $865 | 0.4% |
| 4 | $8.66 | 400 | $3K | 1.6% |
| 5 | $8.67 | 400 | $3K | 1.6% |
| 6 | $8.68 | 300 |
| $3K |
| 1.2% |
| 7 | $8.69 | 500 | $4K | 2.0% |
| 8 | $8.70 | 700 | $6K | 2.8% |
| 9 | $8.71 | 3,500 | $30K | 13.9% |
| 10 | $8.72 | 950 | $8K | 3.8% |
| 11 | $8.73 | 276 | $2K | 1.1% |
| 12 | $8.74 | 224 | $2K | 0.9% |
| 13 | $8.75 | 1,500 | $13K | 6.0% |
| 14 | $8.76 | 1,350 | $12K | 5.4% |
| 15 | $8.77 | 600 | $5K | 2.4% |
| 16 | $8.78 | 600 | $5K | 2.4% |
| 17 | $8.79 | 900 | $8K | 3.6% |
| 18 | $8.80 | 3,010 | $26K | 12.1% |
| 19 | $8.81 | 1,610 | $14K | 6.5% |
| 20 | $8.82 | 1,100 | $10K | 4.4% |
| 21 | $8.83 | 1,880 | $17K | 7.6% |
| 22 | $8.84 | 400 | $4K | 1.6% |
| 23 | $8.85 | 600 | $5K | 2.4% |
| 24 | $8.88 | 700 | $6K | 2.8% |
| 25 | $8.89 | 1,299 | $12K | 5.3% |
| 26 | $8.90 | 600 | $5K | 2.4% |
| 27 | $8.91 | 201 | $2K | 0.8% |
| 28 | $8.92 | 700 | $6K | 2.8% |
| 29 | $8.93 | 100 | $893 | 0.4% |
| Total | $8.78 avg | 25,000 | $220K | 100% |
| Filing → |
| ERAS | BUY | 2023-06-08 | $275K | — | Filing → |
| ERAS | BUY | 2023-03-28 | $284K | — | Filing → |
| ERAS | BUY | 2023-01-10 | $232K | — | Filing → |